CHELMSFORD, Mass., Dec. 1, 2021 /PRNewswire/ -- Azenta, Inc.
(Nasdaq: AZTA) ("Azenta" or the "Company") announced today that it
has completed its previously announced corporate name change from
"Brooks Automation, Inc." to "Azenta, Inc." In conjunction with the
corporate name change, the Company will begin trading on the Nasdaq
Global Select Market under the new ticker symbol, AZTA, effective
at the open of market trading on December 1,
2021.
This change follows the launch of the Company's life sciences
brand, Azenta Life Sciences and the Investor Day held on
November 16, 2021. The Company
anticipates completion of the sale of the semiconductor automation
business in the first half of calendar year 2022, at which time the
Company will become a pure play life sciences company.
About Azenta
Azenta (Nasdaq: AZTA) is a leading
provider of life sciences solutions worldwide, enabling impactful
breakthroughs and therapies to market faster. Azenta provides a
full suite of reliable cold-chain sample management solutions and
genomic services across areas such as drug development, clinical
research and advanced cell therapies for the industry's top
pharmaceutical, biotech, academic and healthcare institutions
globally.
In addition, the company operates the Semiconductor Solutions
Group business, an industry-leading provider of semiconductor
manufacturing automation and collaborative robotics solutions
worldwide. On September 20, 2021, the
Company announced the pending sale of this business to Thomas H.
Lee Partners. Due to the pending divestiture, the Company began
reporting the Semiconductor Solutions Group business as
discontinued operations in its recent fiscal year-end earnings
announcement.
Azenta is headquartered in Chelmsford,
MA, with operations in North
America, Europe and
Asia. For more information, please
visit www.azenta.com.
"Safe Harbor Statement" under Section 21E of the Securities
Exchange Act of 1934
Some statements in this release are forward-looking statements made
under Section 21E of the Securities Exchange Act of 1934. These
statements are neither promises nor guarantees but involve risks
and uncertainties, both known and unknown, that could cause
Azenta's financial and business results to differ materially from
our expectations. They are based on the facts known to management
at the time they are made. These forward-looking statements include
but are not limited to statements about timing of completion of the
pending sale of our semiconductor automation business, our business
following the sale of our semiconductor automation business and the
trading of our common stock. Factors that could cause results to
differ from our expectations include the following: the
impact of the COVID-19 global pandemic on the markets we serve,
including our supply chain, and on the global economy generally,
the volatility of the industries the Company serves, particularly
the semiconductor industry; our possible inability to meet demand
for our products due to difficulties in obtaining components and
materials from our suppliers in required quantities and of required
quality; the inability of customers to make payments to us when
due; the timing and effectiveness of cost reduction and cost
control measures; price competition; disputes concerning
intellectual property; uncertainties in global political and
economic conditions, and other factors and other risks, including
those that we have described in our filings with the Securities and
Exchange Commission, including but not limited to our Annual Report
on Form 10-K, current reports on Form 8-K and our quarterly reports
on Form 10-Q. As a result, we can provide no assurance that our
future results will not be materially different from those
projected. Azenta expressly disclaims any obligation or undertaking
to release publicly any updates or revisions to any such statement
to reflect any change in our expectations or any change in events,
conditions, or circumstances on which any such statement is based.
Azenta undertakes no obligation to update the information contained
in this press release.
INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Azenta, Inc.
978.262.2635
sara.silverman@azenta.com
Sherry Dinsmore
Azenta, Inc.
978.262.2400
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-inc-nasdaq-azta-announces-completion-of-corporate-name-and-stock-ticker-symbol-change-from-brooks-automation-inc-nasdaq-brks-301434919.html
SOURCE Azenta